# Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis

> **NCT00123149** · PHASE2 · WITHDRAWN · sponsor: **Ortho Biotech Products, L.P.**

## Conditions studied

- Anemia
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Epoetin alfa

## Key facts

- **NCT ID:** NCT00123149
- **Lead sponsor:** Ortho Biotech Products, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123149, "Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00123149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*